1
|
Bi ZQ: Clinical and pathological analysis
of 40 cases of IgA nephropathy. Zhonghua Nei Ke Za Zhi. 23:136–140.
1984.(In Chinese).
|
2
|
Li LS: Clinicopathological correlation of
34 cases of IgA nephropathy. Zhonghua Nei Ke Za Zhi. 23:336–339.
3971984.(In Chinese).
|
3
|
Berger J, Yaneva H, Nabarra B and Barbanel
C: Recurrence of mesangial deposition of IgA after renal
transplantation. Kidney Int. 7:232–241. 1975. View Article : Google Scholar : PubMed/NCBI
|
4
|
Odum J, Peh CA, Clarkson AR, et al:
Recurrent mesangial IgA nephritis following renal transplantation.
Nephrol Dial Transplant. 9:309–312. 1994.PubMed/NCBI
|
5
|
Kessler M, Hiesse C, Hestin D, et al:
Recurrence of immunoglobulin A nephropathy after renal
transplantation in the cyclosporin era. Am J Kidney Dis. 28:99–104.
1996. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ohmacht C, Kliem V, Burg M, et al:
Recurrent immunoglobulin A nephropathy after renal transplantation:
a significant contributor to graft loss. Transplantation.
64:1493–1496. 1997. View Article : Google Scholar : PubMed/NCBI
|
7
|
Mafsugami K, Naito T, Nitta K, et al: A
clinicopathological study of recurrent IgA nephropathy following
renal transplantation. Nippon Jinzo Gakkai Shi. 40:322–328.
1998.(In Japanese).
|
8
|
Berthoux B, Diconne E, Mariat C, et al:
Risk factors for primary IgA nephropathy recurrence after renal
transplantation (RTx). Nephrol Dial Transplant. 18:801–802.
2003.
|
9
|
Namba Y, Oka K, Moriyama T, et al: Risk
factors for graft loss in patients with recurrent IgA nephropathy
after renal transplantation. Transplant Proc. 36:1314–1316. 2004.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Couser W: Recurrent glomerulonephritis in
the renal allograft: an update of selected areas. Exp Clin
Transplant. 3:283–288. 2005.PubMed/NCBI
|
11
|
Ng YS, Vathsala A, Chew ST, et al: Long
term outcome of renal allografts in patients with immunoglobulin A
nephropathy. Med J Malaysia. 62:109–113. 2007.PubMed/NCBI
|
12
|
Moriyama T, Nitta K, Suzuki K, et al:
Latent IgA deposition from donor kidney is the major risk factor
for recurrent IgA nephropathy in renal transplantation. Clin
Transplant. 19:41–48. 2005. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kiattisunthorn K, Premasathian N,
Wongwiwatana A, et al: Evaluating the clinical course and
prognostic factors of posttransplantation immunoglobulin A
nephropathy. Transplant Proc. 40:2349–2354. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Racusen LC, Solez K, Colvin RB, et al: The
Banff 97 working classification of renal allograft pathology.
Kidney Int. 55:713–723. 1999. View Article : Google Scholar : PubMed/NCBI
|
15
|
Briganti EM, Russ GR, McNeil JJ, et al:
Risk of renal allograft loss from recurrent glomerulonephritis. N
Engl J Med. 347:103–109. 2002. View Article : Google Scholar : PubMed/NCBI
|
16
|
Sanfilippo F, Croker BP and Bollinger RR:
Fate of four cadaveric donor renal allografts with mesangial IgA
deposits. Transplantation. 33:370–376. 1982. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ji S, Liu M, Chen J, et al: The fate of
glomerular mesangial IgA deposition in the donated kidney after
allograft transplantation. Clin Transplant. 18:536–540. 2004.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Berger J: Recurrence of IgA nephropathy in
renal allografts. Am J Kidney Dis. 12:371–372. 1988. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wang AY, Lai FM, Yu AW, et al: Recurrent
IgA nephropathy in renal transplant allografts. Am J Kidney Dis.
38:588–596. 2001. View Article : Google Scholar : PubMed/NCBI
|
20
|
McDonald SP and Russ GR: Recurrence of IgA
nephropathy among renal allograft recipients from living donors is
greater among those with zero HLA mismatches. Transplantation.
82:759–762. 2006. View Article : Google Scholar : PubMed/NCBI
|
21
|
Soler MJ, Mir M, Rodriguez E, et al:
Recurrence of IgA nephropathy and Henoch-Schönlein purpura after
kidney transplantation: risk factors and graft survival. Transplant
Proc. 37:3705–3709. 2005.
|
22
|
Andresdottir MB, Haasnoot GW, Doxiadis II,
et al: Exclusive characteristics of graft survival and risk factors
in recipients with immunoglobulin A nephropathy: a retrospective
analysis of registry data. Transplantation. 80:1012–1018. 2005.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Andresdottir MB, Haasnoot GW, Persijn GG
and Claas FH: HLA-B8, DR3: a new risk factor for graft failure
after renal transplantation in patients with underlying
immunoglobulin A nephropathy. Clin Transplant. 23:660–665. 2009.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Tang Z, Ji SM, Chen DR, et al: Recurrent
or de novo IgA nephropathy with crescent formation after renal
transplantation. Ren Fail. 30:611–616. 2008. View Article : Google Scholar : PubMed/NCBI
|
25
|
Kowalewska J, Yuan S, Sustento-Reodica N,
et al: IgA nephropathy with crescents in kidney transplant
recipients. Am J Kidney Dis. 45:167–175. 2005. View Article : Google Scholar : PubMed/NCBI
|
26
|
Oka K, Imai E, Moriyama T, et al: A
clinicopathological study of IgA nephropathy in renal transplant
recipients: beneficial effect of angiotensin-converting enzyme
inhibitor. Nephrol Dial Transplant. 15:689–695. 2000. View Article : Google Scholar
|